{"id":"NCT04546724","sponsor":"Valneva Austria GmbH","briefTitle":"Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults","officialTitle":"A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Pivotal Study To Evaluate Safety And Immunogenicity Of A Live-Attenuated Chikungunya Virus Vaccine Candidate In Adults Aged 18 Years And Above","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-17","primaryCompletion":"2021-05-19","completion":"2021-10-15","firstPosted":"2020-09-14","resultsPosted":"2022-07-25","lastUpdate":"2023-06-28"},"enrollment":4128,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Chikungunya Virus Infection"],"interventions":[{"type":"BIOLOGICAL","name":"VLA1553","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"VLA1553","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This was a prospective, randomized, double-blinded, multicenter, pivotal clinical study evaluating the final dose of VLA1553 (1 x10E4 TCID50 per dose) in comparison to a placebo control. The final dose of VLA1553 or control was administered as single immunization on Day 1. Overall, 4.128 male and female subjects aged 18 years and above were randomized into the study.","primaryOutcome":{"measure":"Number of Participants With a Seroprotective CHIKV Antibody Level for Baseline Negative Subjects 28 Days Post-vaccination","timeFrame":"on Day 29 after single vaccination","effectByArm":[{"arm":"VLA1553 18-64 Years","deltaMin":204,"sd":null},{"arm":"Placebo 18-64 Years","deltaMin":0,"sd":null},{"arm":"VLA1553 ≥65 Years","deltaMin":59,"sd":null},{"arm":"Placebo ≥65 Years","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":44,"countries":["United States"]},"refs":{"pmids":["39998495","37321235"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":46,"n":3082},"commonTop":["Headache","Fatigue","Myalgia","Arthralgia","Injection site pain"]}}